Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBMYBristol Myers Squibb
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | BMY | GILD |
|---|
| Close | 63.60 | 147.68 |
| Market Cap | $130B | $183B |
| 1M | −1.59% | +6.31% |
| P/E (TTM) | 14.0 | — |
| Forward P/E | 10.4 | 25.3 |
| P/E 5-Yr Percentile | 26 | — |
| P/S | 2.7 | 6.0 |
| P/B | 5.8 | 15.3 |
| Dividend Yield | 4.58% | 3.98% |
| Latest Quarter Revenue | $13.0B | $7.8B |
| Revenue YoY | +5.7% | +10.2% |
| Gross Margin | 71.3% | 79.8% |
| Latest Quarter EPS | 1.62 | -8.45 |
| Avg Post-Earnings Move | ±2.2% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.92% | 3.01% |
| 90-Day Net Insider Buying | −$0.44M | −$15.4M |
BMY · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
